MedPath

TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1211592001

Prescription Type

Uso Hospitalario

Authorization Date

Nov 26, 2021

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211592001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

SACITUZUMAB GOVITECANActive
Quantity: 200 mg
Name: SACITUZUMAB GOVITECAN

ATC CLASSIFICATION (3)

L01F
L01FX
L01FX17

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.